BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21156847)

  • 1. The PP2A inhibitor SET regulates granzyme B expression in human natural killer cells.
    Trotta R; Ciarlariello D; Dal Col J; Mao H; Chen L; Briercheck E; Yu J; Zhang J; Perrotti D; Caligiuri MA
    Blood; 2011 Feb; 117(8):2378-84. PubMed ID: 21156847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PP2A inhibitor SET regulates natural killer cell IFN-gamma production.
    Trotta R; Ciarlariello D; Dal Col J; Allard J; Neviani P; Santhanam R; Mao H; Becknell B; Yu J; Ferketich AK; Thomas B; Modi A; Blaser BW; Perrotti D; Caligiuri MA
    J Exp Med; 2007 Oct; 204(10):2397-405. PubMed ID: 17875674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome.
    Cifaldi L; Prencipe G; Caiello I; Bracaglia C; Locatelli F; De Benedetti F; Strippoli R
    Arthritis Rheumatol; 2015 Nov; 67(11):3037-46. PubMed ID: 26251193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells.
    Oberoi P; Jabulowsky RA; Bähr-Mahmud H; Wels WS
    PLoS One; 2013; 8(4):e61267. PubMed ID: 23573299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity.
    Gerada C; Steain M; Campbell TM; McSharry B; Slobedman B; Abendroth A
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-trans retinoic acid (ATRA) induces miR-23a expression, decreases CTSC expression and granzyme B activity leading to impaired NK cell cytotoxicity.
    Sanchez-Martínez D; Krzywinska E; Rathore MG; Saumet A; Cornillon A; Lopez-Royuela N; Martínez-Lostao L; Ramirez-Labrada A; Lu ZY; Rossi JF; Fernández-Orth D; Escorza S; Anel A; Lecellier CH; Pardo J; Villalba M
    Int J Biochem Cell Biol; 2014 Apr; 49():42-52. PubMed ID: 24440757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.
    Yu Y; Hagihara M; Ando K; Gansuvd B; Matsuzawa H; Tsuchiya T; Ueda Y; Inoue H; Hotta T; Kato S
    J Immunol; 2001 Feb; 166(3):1590-600. PubMed ID: 11160200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs.
    Fehniger TA; Cai SF; Cao X; Bredemeyer AJ; Presti RM; French AR; Ley TJ
    Immunity; 2007 Jun; 26(6):798-811. PubMed ID: 17540585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFNalpha2b stimulated release of IFNgamma differentially regulates T cell and NK cell mediated tumor cell cytotoxicity.
    Bose A; Baral R
    Immunol Lett; 2007 Jan; 108(1):68-77. PubMed ID: 17112599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of granzyme B and C in murine cytotoxic lymphocytes.
    Cai SF; Fehniger TA; Cao X; Mayer JC; Brune JD; French AR; Ley TJ
    J Immunol; 2009 May; 182(10):6287-97. PubMed ID: 19414782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment in cytotoxicity and expression of NK cell- activating receptors on human NK cells following exposure to asbestos fibers.
    Nishimura Y; Miura Y; Maeda M; Kumagai N; Murakami S; Hayashi H; Fukuoka K; Nakano T; Otsuki T
    Int J Immunopathol Pharmacol; 2009; 22(3):579-90. PubMed ID: 19822075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential cytokine regulation of natural killer cell-mediated necrotic and apoptotic cytotoxicity.
    Gardiner CM; Reen DJ
    Immunology; 1998 Apr; 93(4):511-7. PubMed ID: 9659223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies.
    Friedman J; Morisada M; Sun L; Moore EC; Padget M; Hodge JW; Schlom J; Gameiro SR; Allen CT
    J Immunother Cancer; 2018 Jun; 6(1):59. PubMed ID: 29925431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of perforin and granzyme messenger RNA expression in human natural killer cells.
    Salcedo TW; Azzoni L; Wolf SF; Perussia B
    J Immunol; 1993 Sep; 151(5):2511-20. PubMed ID: 8103068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells.
    DeBlaker-Hohe DF; Yamauchi A; Yu CR; Horvath-Arcidiacono JA; Bloom ET
    Cell Immunol; 1995 Oct; 165(1):33-43. PubMed ID: 7671323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of c-Myb in the regulation of natural killer cell activity.
    Shin HW; Lee YJ; Kim J
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2807-2813. PubMed ID: 30103947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway.
    Vermijlen D; Luo D; Froelich CJ; Medema JP; Kummer JA; Willems E; Braet F; Wisse E
    J Leukoc Biol; 2002 Oct; 72(4):668-76. PubMed ID: 12377935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity.
    Krzewski K; Gil-Krzewska A; Nguyen V; Peruzzi G; Coligan JE
    Blood; 2013 Jun; 121(23):4672-83. PubMed ID: 23632890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat CD4+CD8+ macrophages kill tumor cells through an NKG2D- and granzyme/perforin-dependent mechanism.
    Baba T; Iwasaki S; Maruoka T; Suzuki A; Tomaru U; Ikeda H; Yoshiki T; Kasahara M; Ishizu A
    J Immunol; 2008 Mar; 180(5):2999-3006. PubMed ID: 18292522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of granzyme B and perforin gene expression in the lytic potential of human natural killer cells.
    Clément MV; Haddad P; Soulié A; Legros-Maida S; Guillet J; Cesar E; Sasportes M
    Res Immunol; 1990; 141(6):477-89. PubMed ID: 2284495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.